Dysregulation of chemokine receptor expression and function in leukocytes from ALS patients

[1]  Stephen A. Goutman,et al.  Correlation of Peripheral Immunity With Rapid Amyotrophic Lateral Sclerosis Progression , 2017, JAMA neurology.

[2]  Jia Liu,et al.  Role of Neuroinflammation in Amyotrophic Lateral Sclerosis: Cellular Mechanisms and Therapeutic Implications , 2017, Front. Immunol..

[3]  O. Witte,et al.  Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease , 2017, Neurology.

[4]  Shanker Kalyana-Sundaram,et al.  Characterization of Gene Expression Phenotype in Amyotrophic Lateral Sclerosis Monocytes , 2017, JAMA neurology.

[5]  V. Piazza,et al.  Immune response in peripheral axons delays disease progression in SOD1G93A mice , 2016, Journal of Neuroinflammation.

[6]  F. Zouein,et al.  The CXCL10/CXCR3 Axis and Cardiac Inflammation: Implications for Immunotherapy to Treat Infectious and Noninfectious Diseases of the Heart , 2016, Journal of immunology research.

[7]  B. Solomon,et al.  Chronic administration of AMD3100 increases survival and alleviates pathology in SOD1G93A mice model of ALS , 2016, Journal of Neuroinflammation.

[8]  A. Ludolph,et al.  Peripheral monocytes are functionally altered and invade the CNS in ALS patients , 2016, Acta Neuropathologica.

[9]  K. Ley,et al.  Integrin-based therapeutics : biological basis , clinical use and new drugs , 2016 .

[10]  T. Zesiewicz,et al.  Humoral factors in ALS patients during disease progression , 2015, Journal of Neuroinflammation.

[11]  I. Chiu,et al.  T lymphocytes potentiate endogenous neuroprotective inflammation in a mouse model of ALS , 2008, Proceedings of the National Academy of Sciences.

[12]  S. Appel,et al.  CD4+ T cells support glial neuroprotection, slow disease progression, and modify glial morphology in an animal model of inherited ALS , 2008, Proceedings of the National Academy of Sciences.

[13]  T. Holmøy,et al.  T cells in amyotrophic lateral sclerosis , 2008, European journal of neurology.

[14]  R. Ransohoff,et al.  Chemokines and chemokine receptors in neurological disease: Raise, retain, or reduce? , 2007, Neurotherapeutics.

[15]  L. Ferraiuolo,et al.  Microarray Analysis of the Cellular Pathways Involved in the Adaptation to and Progression of Motor Neuron Injury in the SOD1 G93A Mouse Model of Familial ALS , 2007, The Journal of Neuroscience.

[16]  C. Geula,et al.  Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease , 2007, Nature Medicine.

[17]  M. McGrath,et al.  MCP-1 chemokine receptor CCR2 is decreased on circulating monocytes in sporadic amyotrophic lateral sclerosis (sALS) , 2006, Journal of Neuroimmunology.